Status:
RECRUITING
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Ovarian Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy
Detailed Description
Objectives: * Create a low literacy version of a shared decision-making (SDM) tool for ovarian cancer maintenance therapy for Spanish speaking individuals. * To explore the feasibility and acceptabil...
Eligibility Criteria
Inclusion
- Study population: This study will enroll patients and clinical providers.
- Inclusion criteria: Patients
- • Eligible patients must be: 1) individuals ≥ 18 years with advanced stage high grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are receiving or have completed platinum-based chemotherapy for ovarian cancer and are potentially eligible to receive maintenance therapy; 2) able to understand, speak or read in Spanish.
- Exclusion criteria: Patients
- • Inability or unwillingness to sign informed consent
- Inclusion criteria: Clinicians
- • Eligible clinicians will include: 1) MD Anderson gynecologic oncologists and advanced practice providers who practice at the Houston Area Locations (HALs), MD Anderson Cancer Center, or our county safety net hospital, The Harris Health System (LBJ Hospital).
- Exclusion criteria: Clinicians
- • Inability or unwillingness to sign informed consent
Exclusion
Key Trial Info
Start Date :
August 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2027
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06036810
Start Date
August 31 2023
End Date
October 31 2027
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030